1. Home
  2. IRON vs TRMD Comparison

IRON vs TRMD Comparison

Compare IRON & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$73.54

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo TORM plc

TRMD

TORM plc

HOLD

Current Price

$24.83

Market Cap

2.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
TRMD
Founded
2017
1889
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IRON
TRMD
Price
$73.54
$24.83
Analyst Decision
Strong Buy
Buy
Analyst Count
12
1
Target Price
$110.08
$23.00
AVG Volume (30 Days)
526.7K
529.0K
Earning Date
02-26-2026
03-05-2026
Dividend Yield
N/A
8.11%
EPS Growth
N/A
N/A
EPS
N/A
2.76
Revenue
N/A
$1,292,300,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$9.01
Revenue Growth
N/A
N/A
52 Week Low
$30.82
$13.60
52 Week High
$99.50
$24.96

Technical Indicators

Market Signals
Indicator
IRON
TRMD
Relative Strength Index (RSI) 41.49 67.75
Support Level $76.00 $23.94
Resistance Level $83.93 $24.93
Average True Range (ATR) 4.20 0.71
MACD 0.20 0.07
Stochastic Oscillator 13.69 93.03

Price Performance

Historical Comparison
IRON
TRMD

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About TRMD TORM plc

TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Engineering segment. The company derives maximum revenue from Tanker segment.

Share on Social Networks: